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Aims: To (1) correlate peak and maximum flow rates from non-instrumented flow (NIF) and pressure-flow studies
(PFS) in women with pelvic organ prolapse (POP); (2) measure the impact of voided volume and degree of prolapse
on correlations. Methods: We compared four groups of women with stages II–IV POP. Groups 1 and 2 were
symptomatically stress continent women participating in the colpopexy and urinary reduction efforts (CARE) trial;
during prolapse reduction before sacrocolpopexy, Group 1 (n ¼ 67) did not have and Group 2 (n ¼ 84) had
urodynamic stress incontinence (USI). Group 3 (n ¼ 74) and Group 4 participants (n ¼ 73), recruited specifically for
this study, had stress urinary incontinence (SUI) symptoms. Group 3 planned sacrocolpopexy. Group 4 planned a
different treatment option. Participants completed standardized uroflowmetry and pressure voiding studies.
Results: Subjects’ median age was 61 years; median parity 3% and 80% had stage III or IV POP. Based on the
Blaivas–Groutz nomogram, 49% of all women were obstructed. NIF and PFS peak and average flow rates had low
correlations with one another (0.31, P < 0.001 and 0.35, P < 0.001, respectively). When NIF and PFS voided volumes
were within 25% of each other, the peak and average flow rate correlations improved (0.52, P < 0.001 and 0.57,
P < 0.001, respectively). As vaginal prolapse increased, correlations between NIF and PFS peak and average flow
rates decreased. Conclusion: Peak and average flow rates are highly dependent on voided volume in women with
prolapse. As the prolapse stage increases, correlations between NIF and PFS variables decrease. Neurourol.
Urodynam. 27:515–521, 2008.  2008 Wiley-Liss, Inc.
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INTRODUCTION
Women with pelvic organ prolapse (POP) may experience a
variety of urinary symptoms, ranging from urinary leakage to
obstructive voiding. Obstructive symptoms are common in
prolapse and may reflect patho-physiologic obstruction during
the voiding phase of micturition. Symptoms suggestive of
obstruction, such as a decreased force of stream, urinary
hesitancy, straining and need to manually manipulate
prolapse occur in 14–76% of women with prolapse1,2 and
these voiding difficulties have been associated with increasing
severity of prolapse.3 These clinical observations lend cre-
dence to the hypothesis that the urethra is ‘‘functionally
obstructed’’ in advanced stages of prolapse.4
The ability to diagnose bladder outlet obstruction (BOO)
may assist the clinician in determining whether obstructive
symptoms are attributable to prolapse. The most common
office-based measures for BOO are simple non-instrumented
uroflowmetry study (NIF) and an assessment of post-void
residual volume (PVR). A NIF requires a woman to urinate into
a device that measures the weight of the fluid by time. The
output is typically a curve of flow rate (ml/sec) versus time.
The area under the curve is the total volume of the urination.
Women with prolapse generally have larger PVR’s and lower
urinary flow rates by NIF compared to women with urinary
incontinence and no prolapse.5 The pressure-flow study (PFS)
is performed by urinating into a flow device with a small
catheter placed transurethrally into the bladder so that
vesical pressure can be measured simultaneously. PFS provide
a flow curve similar to uroflowmetry in addition to a measure
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of the vesical pressure. The transurethral catheter lowers
the peak flow rates obtained in women with and without
BOO.4
Among men with benign prostatic hyperplasia where BOO
is highly prevalent, obstructed voiding is differentiated
from non-obstructed voiding by nomograms that use the PFS
values of peak flow (Qmax) and detrusor pressure at peak
flow (PdetQmax).
6–8 A nomogram specifically for women with
symptoms of BOO, the Blaivis–Groutz nomogram, uses Qmax
from the NIF and the maximum detrusor pressure (Pdetmax)
from the PFS.8 The NIF Qmax was preferred by the authors
because many of the obstructed subjects had low peak flow
rates due to the transurethral catheter. The Pdetmax was
preferred to the PdetQmax because they were found to not be
statistically different and in cases of retention, no value for
PdetQmax could be obtained.
The relationship between peak and average flow rates
obtained during NIF and PFS is largely unstudied in women
with prolapse. It is unknown whether the urethral catheter
stents the potentially obstructed urethra during voiding in a
PFS in women with prolapse, thereby underestimating the
frequency and/or degree of functional urethral obstruction
associated with prolapse.
The primary aim of this study was to investigate the
relationship of urine flow rates during NIF and PFS in women
with POP. We also wanted to better understand how the
voided volume and degree of prolapse influenced flow
variables obtained during NIF and PFS. For example, some
evidence suggests that low voided volumes (e.g., <150 ml)
negatively impact the reliability of test results.9 To achieve
these aims, we conducted a prospective supplementary
study to the NIH/NICHD’s Pelvic Floor Disorders Network
(PFDN) colpopexy and urinary reduction efforts (CARE) trial.10
The CARE trial enrolled women without symptoms of
stress incontinence (SUI) undergoing sacrocolpopexy for POP
with the primary aim of determining if adding a Burch
colposuspension at the time of prolapse surgery would
reduce symptoms of stress incontinence post-operatively.
For this supplementary study, we also enrolled women with
prolapse and symptoms of SUI. This provided a sample of
women with prolapse and a broad spectrum of urinary
symptoms in which to study voiding parameters during NIF
and PFS.
METHODS
This study was approved by the Institutional Review Board
of each participating center. All participants signed informed
consent before any study procedures were done. Participants
included 298 women with stages II–IV POP, divided into four
groups, as follows:
(1) Group 1, stress continent: 67 women randomly selected
from women enrolled in the colpopexy and urinary
reduction efforts (CARE) trial10 who were defined as stress
continent and demonstrated no urodynamic stress incon-
tinence (USI) with prolapse reduction.
(2) Group 2, occult SUI: 84 women randomly selected from
women enrolled in the CARE trial who were defined as
stress continent and demonstrated USI with prolapse
reduction (i.e., urinary leakage from the urethral meatus
with cough or Valsalva with the prolapse reduced).
(3) Group 3, stress incontinent: 74 women who met the
same eligibility criteria for the CARE trial (i.e., they were
planning sacrocolpopexy for prolapse) except they
were stress incontinent.
(4) Group 4, stress incontinent: 73 women who had
prolapse and SUI symptoms but they were not planning
sacrocolpopexy.
CARE subjects were considered stress continent (and
thus eligible for CARE) if they responded ‘‘never’’ or ‘‘rarely’’
to six of the stress incontinence questions from the
Medical, epidemiological, and social aspects of aging (MESA)
questionnaire (coughing hard, sneezing, lifting, bending,
laughing, and walking briskly or jogging); and stress incon-
tinent if they responded ‘‘sometimes’’ or ‘‘usually’’ to any
of these same MESA questions.11 Women enrolled in the CARE
trial and those recruited for this supplementary study under-
went identical standardized urodynamics procedures and
pelvic organ prolapse quantification (POP-Q)12 examination
by certified research nurses.
For this supplementary study, subjects were included only
if they answered affirmatively to either of two questions
about seeing or feeling a vaginal bulge.13 Additionally, women
in groups 1–3 were included only if POP-Q point Aa was
located 1 cm above the hymen or lower, while women in
group 4 did not have this requirement.
The urodynamics protocol, including quality control measures,
has been described in detail elsewhere.14 In brief, participants
underwent NIF followed by non-fluoroscopic urodynamic
studies with external water pressure transducers. Women were
instructed to come to this appointment with a comfortably
full bladder. Non-instrumented uroflowmetry was done with
participants in a seated position. Post-void residual (PVR) urine
volume was obtained by catheterization within 15 min of NIF.
The same multi-channel urodynamic recorder was used for
all urodynamic studies. The cystometrogram was performed
with participants seated at a 45 angle, using 8 French
lumen external water transducer catheters that were zeroed to
atmospheric pressure at the superior level of the symphysis
pubis prior to insertion. Intravesical pressure (Pves), intra-
abdominal pressure (Pabd), and subtracted detrusor pressure
(Pdet) were continuously recorded. The bladder was filled with
room temperature sterile saline or water at 50 ml/min. A
rectal catheter was used to estimate intra-abdominal pressure.
During filling cystometry Valsalva and cough leak point
pressures were obtained at 300 ml and maximum cystometric
capacity (MCC) with the prolapse reduced by one of three
methods that were randomized to the center performing the
study.
The PFS was done with the prolapse reduction method
removed. The subject was instructed to bear down or cough to
encourage the prolapse to become maximal again prior to
voiding. Urethral relaxation was not documented during the
pressure-flow voiding study.
We assessed voiding obstruction using the parameters of
non-instrumented peak flow rate (Qmax NIF) and maximum
detrusor pressure (Pdetmax) from the PFS as outlined by Blaivas
and Groutz.4 The void was defined as obstructed when values
fell outside of the ‘‘unobstructed area’’ on the nomogram.
Urinary retention was defined as voiding <75% of total
bladder volume. Total bladder volume was defined as the
voided volume plus the PVR. Maximum bladder capacity was
defined as the volume during filling cystometry at which
women stated they could no longer delay a trip to the
bathroom.
Statistical Analysis
The four groups were compared by either a chi-square test
when the measure was discrete or by an analysis of variance
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when the measure was continuous. The non-parametric
paired sign test was used to compare differences between
paired data. Urodynamic data for the four groups were
also compared after adjustment for age as a continuous
measure and prior surgery for prolapse or incontinence as a
dichotomous measure. Correlations were computed to
assess associations between measures. With approximately
70 subjects per group there is greater than 80% power to
identify a difference of 0.5 SD when testing a continuous
outcome or a difference of 25% when testing a dichotomous
outcome at a 5% level of significance.
Prior to performing the scatter plots, we restricted the data
to voided volumes either >150 or >50 ml (depending on the
analysis) for both NIF and PFS. In addition, we performed a box
plot and whisker graphs and removed data points that were
‘‘outliers.’’ Data for the scatter plots were analyzed using SPSS
software (Chicago, IL).
RESULTS
Demographic characteristics and physical examination
findings of the four groups, shown in Table I, were similar
except women with occult SUI (Group 2) were older (P ¼ 0.022)
and the proportion of women that had undergone previous
incontinence surgery differed between the groups (P < 0.001).
Across the different groups, peak flow rate, average flow
rate, and PVR did not differ significantly based on the presence
of SUI symptoms or urodynamic diagnosis of stress incon-
tinence (Table II). Peak flow rates were higher in the PFS
compared to the NIF studies. Comparing values obtained from
NIF versus PFS, correlations between peak and average flow
rates were moderate for stress continent women (Group 1;
r ¼ 0.42, P ¼ 0.002; and r ¼ 0.43, P ¼ 0.002, respectively); cor-
relations were lower in the other two groups. PVR measure-
ments obtained during NIF and PFS were not significantly
correlated. Approximately 50% of women were ‘‘obstructed’’
based on the Blaivas–Groutz nomogram independent of
continence status.
Sixty-eight (23%) of women were unable to void for one of
the studies. Only the remaining women with both NIF and
PFS voided volumes >0 ml were included in the correlation
analyses. Total bladder volume was higher in PFS compared to
NIF (431  149 ml vs. 316  227 ml, P < 0.001, n ¼ 244), as
were mean voided volumes (386  174 ml vs. 246  202 ml,
P < 0.001, n ¼ 239). Peak flow rates obtained during PFS were
higher than those obtained by NIF (22  16 vs.18  10 ml/sec,
P ¼ 0.001, n ¼ 230), average flow rates obtained during
PFS were slightly lower than those obtained by NIF (8 
4 vs.9  6 ml/sec, P ¼ 0.02, n ¼ 215).
As seen in Table III, correlations between NIF and PFS peak
and average flow rates varied from 0.26 to 0.57 based on the
conditions specified. The strongest correlation was seen for
PFS and NIF voided volumes within 25% of one another: the
mean total bladder volume was similar (466  196 ml vs.
471  194 ml, P ¼ 0.68) although mean voided volumes by PFS
were slightly higher than by NIF (404  215 ml vs.
383  188 ml, P ¼ 0.04). In contrast to the findings for the
entire group, peak and average flow rates were higher by NIF
compared to PFS (peak: 22  9 vs. 20  14 ml/sec, P ¼ 0.008,
n ¼ 55; average: 11  6 vs. 7  4 ml/sec, P < .001). Restricting
the analysis to voided volumes by NIF and PFS >150 ml did not
improve the correlations from the original analyses (i.e.,
analyses excluding only those who could not void by NIF
and PFS). Correlations in peak flow rates decreased as the
maximal vaginal descent increased.
In order to better understand the relationship of flow rates
and voided volume, we performed scatter plots of NIF and PFS
flow rates versus their respective voided volumes. Box plots of
NIF and PFS peak and average flow rates were performed to
remove outliers (Fig. 1). For women who voided 150 ml,
the majority of the outliers in peak flow rates were seen in the
flow measurements taken during the PFS and there were none
in NIF. Peak flow rate outliers were 58 ml/sec. Outlier values
for PFS and NIF average flow rates were 21 and 25 ml/sec,
respectively.
For the first graphical analysis we limited the data to
women who voided 150 ml for each of the studies. For
the second analysis we limited the data to women who voided
50 ml for each of the studies.
As demonstrated in Figure 2, in women who voided
150 ml, NIF and PFS peak flow rates increased with
increasing voided volumes and is represented by the following
linear equations,
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TABLE I. Demographic and Clinical Characteristics of 298 Women With Prolapse, Grouped by Stress Continence Status
Characteristic
Stress continent
Group 1 (n ¼ 67)
Occult SUI
Group 2 (n ¼ 84)
Stress incontinent
Group 3 (n ¼ 74)
Stress incontinent
Group 4 (n ¼ 73)
Age in years: mean  SD 58  10 62  11 57  14 60  14
Parity: median (range) 2 (1–8) 3 (1–7) 3 (0–8) 3 (0–7)
POP-Q stage: n (%)
Stage II 8 (12%) 11 (13%) 10 (13.5%) 32 (44%)
Stage III 48 (72%) 61 (73%) 54 (73%) 36 (49%)
Stage IV 11 (16%) 12 (14%) 10 (13.5%) 5 (7%)
Prior surgery for POP: n (%) 18 (27%) 35 (42%) 30 (41%) 19 (26%)
Prior surgery for UI: n (%) 0 (0%) 8 (10%) 19 (26%) 16 (22%)
Maximum anterior prolapse (cm): mean  SD þ3.0  2.5 þ3.2  2.6 þ2.8  2.8 þ1.4  2.5
Maximum vaginal descent (cm): mean  SD þ3.6  2.2 þ3.9  2.2 þ3.6  2.4 þ1.9  2.2
More women in Groups 2, 3 and 4 each had prior surgery for UI than in Group 1 (P < 0.001).
Maximum anterior prolapse based on point Ba from POP-Q, maximal vaginal descent based on most distal POP-Q point.
There are no statistically significant differences between groups except for the following characteristics.
Women in Group 2 are older than the other three groups (P ¼ 0.02).
NIF : Qmax ml=sec ¼ 0:023ðVoided VolumeÞ þ 13:5 ml=sec; n ¼ 115; r2 ¼ 0:23
PFS : Qmax ml=sec ¼ 0:023ðVoided VolumeÞ þ 9:5 ml=sec; n ¼ 115; r2 ¼ 0:15
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A similar relationship was found for average flow rates in
women who voided 150 ml. The scatter plot for average flow
rates versus voided volume is similar and is represented by the
following linear equations:
NIF :Qavg ml=sec¼0:011ðVoided VolumeÞþ6:6 ml=sec; r2 ¼ 0:17
PFS :Qavg ml=sec¼0:012ðVoided VolumeÞþ2:8 ml=sec; r2 ¼ 0:21
we repeated the graphical analysis and included women
who voided 50 ml for both studies and found that the linear
relationship between the PFS peak flow rate and voided
volume was unchanged but the relationship between the NIF
and voided volume changed (Fig. 3):
The results for average flow rates demonstrate a minimal
change in the slope and y-intercept; however, the lines do not
intersect at any volume.
DISCUSSION
We previously demonstrated a 60% rate of urinary obstruc-
tion in women with stage II–IV POP using the Blaivas–Groutz
obstruction nomogram for women.15 We found that symptoms
of obstruction and retention correlated poorly with urodynamic
findings of obstruction. We also found that women with
prolapse and USI had the same urine flow rates as women with
prolapse without USI. We hypothesized that this occurs because
stress incontinence results from a loss of sphincteric integrity
and during urination the sphincter is open.
The Blaivas–Groutz nomogram was developed from
50 women with symptomatic BOO and included 10 women
with severe genital prolapse. As noted in the introduction, the
nomogram uses the peak flow from the NIF and the PdetQmax
from the PFS. We questioned how peak flows obtained in a NIF
Neurourology and Urodynamics DOI 10.1002/nau
TABLE III. Correlations Between NIF and PFS Flow Ratesa
Peak flow rate
r-value, P-value, n Condition Average flow rate r-value, P-value, n
0.31, <0.001, 230 All 0.35, <0.001, 215
0.52, <0.001, 56 Voided volumes within 25% 0.57, <0.001, 54
0.32, <0.001, 174 Voided volumes NOT within 25% 0.30, <0.001, 161
0.34, <0.001, 135 Voided volumes NIF and PFS both >150 ml 0.41, <0.001, 129
0.40, 0.004, 56 Maximal vaginal descent <2 cmb 0.33, 0.02, 51
0.29, 0.006, 91 Maximal vaginal descent 2 and <4 cmb 0.42, <0.001, 85
0.26, 0.078, 46 Maximal vaginal descent 4 and <6 cmb 0.29, 0.06, 43
0.20, 0.22, 41 Maximal vaginal descent 6 cmb 0.26, 0.125, 36
aThis analysis was restricted to woman who could void for both studies.
bMaximal vaginal descent is defined as most distal POP-Q point.
TABLE II. Voiding and Urodynamic Parameters by Cohort
Characteristic
No SUI
Group 1 (n ¼ 67)
Occult SUI G
roup 2 (n ¼ 84)
Overt SUI
Group 3 (n ¼ 74)
Overt SUI
Group 4 (n ¼ 73)
Qmax mean  SD (ml/sec)
NIF 17  10 18  11 17  10 20  11
PFS 21  14 20  14 23  17 24  15
NIF–PFS correlation, r (P-value) 0.42 (0.002) 0.26 (0.03) 0.40 (0.003) 0.19 (0.17)
Qavg mean  SD (ml/sec)
NIF 8  6 9  6 8  6 10  6
PFS 8  5 8  4 7  4 9  5
NIF–PFS correlation, r (P-value) 0.44 (0.002) 0.28 (0.02) 0.43 (0.003) 0.28 (0.05)
PVR median (range) ml/sec
NIF 50 (0–520) 50 (0–600) 40 (0–276) 60 (2–425)
PFS 33 (0–381) 25 (0–821) 30 (0–390) 32 (0–529)
NIF–PFS correlation, r (P-value) 0.04 (0.76) 0.03 (0.82) 0.32 (0.01) 0.10 (0.45)
Obstruction on nomogram n
(%)
31 (48%) 38 (51%) 25 (41%) 33 (58%)
NIF : Qmax ml=sec ¼ 0:031ðVoided VolumeÞ þ 9:4 ml=sec; n ¼ 169; r2 ¼ 0:19
PFS : Qmax ml=sec ¼ 0:023ðVoided VolumeÞ þ 9:5 ml=sec; n ¼ 169; r2 ¼ 0:40
NIF : Qavg ml=sec ¼ 0:015ðVoided VolumeÞ þ 4:5 ml=sec; n ¼ 169; r2 ¼ 0:28
PFS : Qavg ml=sec ¼ 0:012ðVoided VolumeÞ þ 2:6 ml=sec; n ¼ 169; r2 ¼ 0:34
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compare to those obtained in the same woman during PFS. To
our knowledge, this is the first study to look at the correlation
between peak and average flows obtained during the NIF and
PFS in women with prolapse.
We saw moderate correlations in peak and average flow
rates between NIF and PFS.8 It is known that NIF and PFS flow
rates increase with increasing voided volumes and that when
voided volumes are low, flow rates can be unreliable.9 We
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Fig. 1. Boxplot of NIF and PFS Peak and average flow rates (cc/sec) for women who voided a minimum of 150 cm3
for each study.
Fig. 2. Peak flow versus voided volume (NIF and PFS voided volume 150 cm3, outliers out).
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therefore performed a sub analysis of women with voided
volumes for NIF and PFS over 150 ml, a cutoff that has
been previously reported to be pertinent;16 however, the
correlations did not improve. It has been suggested that it may
be more appropriate to compare NIF and PFS from voids
with similar voided volumes rather than using an arbitrary
cutoff of 150 ml.17 We observed the highest correlations in
peak flow rates (r ¼ 0.52) and average flow rates (r ¼ 0.57)
when comparisons between NIF and PFS studies were
limited to those voids with voided volumes within 25% of
each other. As the maximal vaginal descent increased
the correlation between NIF and PFS peak and average
flows decreased and with descent 4 cm there was no
statistically significant P values associated with the flow rate
correlations.
As previously mentioned, the difficulty with flow rate
correlations is that they are confounded by differences in
voided volumes between the NIF and PFS studies. Women had
higher total bladder and voided volumes during PFS compared
to NIF. PFS were performed to MCC while women were
instructed to arrive with a comfortably full bladder for the NIF.
There is also a significant amount of individual variation in
flow rates and bladder volumes for ‘‘normal’’ women and
previous authors have recommended the need for repeated
measurements to obtain a mean value18,19 Given these
limitations, it is not surprising that correlations between NIF
and PFS flow rates in this study are generally low and improve
when voided volumes are similar.
We found higher values for peak flow rates in the PFS
compared to the NIF when we included all women who could
void for both studies. This is contrary to previous observations
made by others.4,16 The observation of higher values for peak
flow rates in the PFS compared to the NIF in this study is
explained by differences in the voided volumes. When the
voided volumes were within 25% of each other, we found
that NIF peak and average flow rates were higher than
those obtained during the PFS for similar voided volumes, as
previously observed in women with and without pro-
lapse4,16,17 and presumably due to lack of instrumentation
during NIF.
Prior to performing scatter plots of flow rates and voided
volumes we removed flow rate outliers. The majority of the
outliers occurred in peak flow PFS measurements (outlier
defined as 58 ml/sec) and were considered physiologically
abnormal when compared to median peak flow rates for NIF
in urodynamically ‘‘normal’’ women of 23 ml/sec.20 The
scatter plots provide some important insights about NIF and
PFS flow rates in women with prolapse. The first is that for
similar voided volumes 150 ml, NIF peak and average flow
rates are higher than PFS. The presence of the catheter appears
to obstruct urine flow in women with prolapse as it does in
women without prolapse. When the voided volumes are
between 50 and 150 ml, the PFS peak flow to voided volume
linear equation remains unchanged; however the NIF peak
flow to voided volume linear regression changes. We hypothe-
size that this occurs due to the presence of the catheter in
the PFS study that while obstructing also acts to ‘‘stent’’ the
urethra resulting in less urethral resistance. The detrusor
pressures are thus transmitted to the urine flow allowing
the small amount of urine volume to reach its peak faster
before the volume is excreted. Conversely, during NIF a
portion of the detrusor pressure is applied to overcoming
urethral resistance and as a result less force is available to the
smaller voided volume and as a result, peak flow rates are not
as high. At higher volumes the urethral resistance is overcome
in the early part of urination and all of the detrusor pressure
is applied to the urine stream so we do not observe this
phenomenon.
In women who voided 150 ml we find that peak flow rates
seen with NIF and PFS increased 2.3 ml/100 ml in women with
prolapse. Jorgensen found that NIF peak flow increased
linearly by 5.6 ml/100 ml in women without prolapse.21 This
further supports previous studies that reported reduced flow
rates in women with prolapse.22
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Fig. 3. Peak flow versus voided volume (NIF and PFS voided volume 50 cm3, outliers out).
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Sixty-eight women were unable to void for both the NIF and
PFS studies. Of the 68 who could not urinate, the majority
(69%) could not void during the PFS but could during the NIF.
Multiple factors can contribute to being unable to urinate
with the catheter in place including obstruction from the
prolapse and or catheter, inability to initiate urination during
the PFS due to the laboratory setting and inability to relax the
pelvic floor. Unfortunately, this study did not obtain measures
of urethral function during attempts to urinate. Although a
previous study in women who had advanced prolapse and PFS
with the prolapse reduced and unreduced demonstrated
urethral quieting by concentric needle electromyography
giving credence to the theory of urethral kinking as a
mechanism for obstructive voiding in women.23
One limitation of this study is that the pooled analysis
shows linear r2 values that are low. The square of the
correlation coefficient (r2) is considered a measure of linearity
and also describes how much of the change in peak and
average flow can be attributed to the changes in voided
volume. Since only 15–40% of the difference in peak and
average flow with NIF and PFS are explained by differences
in voided volume, other parameters need to be evaluated.
In this pooled analysis, contributing factors include not
only the within-subject variation of flow rates and voided
volumes but the more significant between-subject variation
which results in fivefold higher standard deviations in flow
rates.19
The use of voiding studies to direct clinical care in women
with prolapse is uncertain. What additional value can be gained
from voiding studies for women who plan treatment of POP?
Clearly routine voiding studies play no role in discriminating
which woman has storage phase abnormalities, such as stress
incontinence. Thus it is illogical to use a voiding study phase to
‘‘triage’’ the stress incontinence procedure.15 The classic use of
voiding studies to diagnose obstruction is most likely unneces-
sary in this group since the elevated urethral pressures caused
by ‘‘urethral kinking’’ resolve with prolapse reduction and the
elevated PVR nearly universally returns to the normal range.23,24
In addition, the obstruction caused by prolapse is often
temporary and resolves when the women lies down or reduces
the prolapse manually. This is certainly not the case in men
with BOO due an enlarged prostate. This finding may explain
why advanced stages of prolapse are not typically associated
with upper urinary tract compromise.25
This study confirms that voided volume, prolapse stage and
the presence of the urethral urodynamics catheter affect
urinary flow rates obtained by NIF and PFS. Since flow rates
are a critical component of nomograms that are being used for
the diagnosis of obstruction, it is important to validate the
nomograms for their use in women with prolapse. Future
studies comparing flow rates in women with and without
prolapse should ideally have similar voided or total bladder
volumes for the NIF and PFS and at a minimum report the total
and voided volumes.
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